O15230 (LAMA5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 138.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Laminin subunit alpha-5 Alternative name(s): Laminin-10 subunit alpha Laminin-11 subunit alpha Laminin-15 subunit alpha | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 3695 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
| Subunit structure | Laminin is a complex glycoprotein, consisting of three different polypeptide chains (alpha, beta, gamma), which are bound to each other by disulfide bonds into a cross-shaped molecule comprising one long and three short arms with globules at each end. Alpha-5 is a subunit of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). |
| Subcellular location | Secreted › extracellular space › extracellular matrix › basement membrane. Note: Major component. |
| Tissue specificity | Expressed in heart, lung, kidney, skeletal muscle, pancreas, retina and placenta. Little or no expression in brain and liver. |
| Domain | Domain G is globular and is part of the major cell-binding site located in the long arm of the laminin heterotrimer. |
| Sequence similarities | Contains 22 laminin EGF-like domains. Contains 5 laminin G-like domains. Contains 1 laminin IV type A domain. Contains 1 laminin N-terminal domain. |
| Sequence caution | The sequence CAC22310.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 35 | 35 | Potential | ||||||||
| Chain | 36 – 3695 | 3660 | Laminin subunit alpha-5 | PRO_0000017062 | |||||||
Regions | |||||||||||
| Domain | 41 – 299 | 259 | Laminin N-terminal | ||||||||
| Domain | 300 – 358 | 59 | Laminin EGF-like 1 | ||||||||
| Domain | 359 – 428 | 70 | Laminin EGF-like 2 | ||||||||
| Domain | 429 – 474 | 46 | Laminin EGF-like 3 | ||||||||
| Domain | 494 – 540 | 47 | Laminin EGF-like 4 | ||||||||
| Domain | 541 – 586 | 46 | Laminin EGF-like 5 | ||||||||
| Domain | 587 – 631 | 45 | Laminin EGF-like 6 | ||||||||
| Domain | 632 – 676 | 45 | Laminin EGF-like 7 | ||||||||
| Domain | 677 – 722 | 46 | Laminin EGF-like 8 | ||||||||
| Domain | 723 – 775 | 53 | Laminin EGF-like 9 | ||||||||
| Domain | 776 – 828 | 53 | Laminin EGF-like 10 | ||||||||
| Domain | 829 – 850 | 22 | Laminin EGF-like 11; truncated | ||||||||
| Domain | 1438 – 1483 | 46 | Laminin EGF-like 12 | ||||||||
| Domain | 1484 – 1527 | 44 | Laminin EGF-like 13 | ||||||||
| Domain | 1528 – 1576 | 49 | Laminin EGF-like 14 | ||||||||
| Domain | 1577 – 1627 | 51 | Laminin EGF-like 15 | ||||||||
| Domain | 1628 – 1637 | 10 | Laminin EGF-like 16; first part | ||||||||
| Domain | 1641 – 1830 | 190 | Laminin IV type A | ||||||||
| Domain | 1831 – 1863 | 33 | Laminin EGF-like 16; second part | ||||||||
| Domain | 1864 – 1912 | 49 | Laminin EGF-like 17 | ||||||||
| Domain | 1913 – 1968 | 56 | Laminin EGF-like 18 | ||||||||
| Domain | 1969 – 2022 | 54 | Laminin EGF-like 19 | ||||||||
| Domain | 2023 – 2069 | 47 | Laminin EGF-like 20 | ||||||||
| Domain | 2070 – 2116 | 47 | Laminin EGF-like 21 | ||||||||
| Domain | 2117 – 2166 | 50 | Laminin EGF-like 22 | ||||||||
| Domain | 2736 – 2929 | 194 | Laminin G-like 1 | ||||||||
| Domain | 2941 – 3115 | 175 | Laminin G-like 2 | ||||||||
| Domain | 3124 – 3292 | 169 | Laminin G-like 3 | ||||||||
| Domain | 3340 – 3513 | 174 | Laminin G-like 4 | ||||||||
| Domain | 3520 – 3692 | 173 | Laminin G-like 5 | ||||||||
| Region | 851 – 1437 | 587 | Domain IV 1 (domain IV B) | ||||||||
| Region | 2167 – 2735 | 569 | Domain II and I | ||||||||
| Coiled coil | 2203 – 2221 | 19 | Potential | ||||||||
| Coiled coil | 2335 – 2466 | 132 | Potential | ||||||||
| Coiled coil | 2510 – 2670 | 161 | Potential | ||||||||
| Motif | 1722 – 1724 | 3 | Cell attachment site Potential | ||||||||
| Motif | 1838 – 1840 | 3 | Cell attachment site Potential | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 95 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 143 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 243 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 452 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 479 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 900 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 921 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 959 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1330 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1529 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1555 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2196 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2209 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 2303 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 2423 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 2501 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 2568 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 2707 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 3107 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 3209 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3257 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3287 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3626 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 300 ↔ 309 | By similarity | |||||||||
| Disulfide bond | 302 ↔ 322 | By similarity | |||||||||
| Disulfide bond | 324 ↔ 333 | By similarity | |||||||||
| Disulfide bond | 336 ↔ 356 | By similarity | |||||||||
| Disulfide bond | 359 ↔ 368 | By similarity | |||||||||
| Disulfide bond | 361 ↔ 393 | By similarity | |||||||||
| Disulfide bond | 396 ↔ 405 | By similarity | |||||||||
| Disulfide bond | 408 ↔ 426 | By similarity | |||||||||
| Disulfide bond | 429 ↔ 440 | By similarity | |||||||||
| Disulfide bond | 431 ↔ 447 | By similarity | |||||||||
| Disulfide bond | 449 ↔ 458 | By similarity | |||||||||
| Disulfide bond | 461 ↔ 471 | By similarity | |||||||||
| Disulfide bond | 494 ↔ 506 | By similarity | |||||||||
| Disulfide bond | 496 ↔ 515 | By similarity | |||||||||
| Disulfide bond | 517 ↔ 526 | By similarity | |||||||||
| Disulfide bond | 529 ↔ 538 | By similarity | |||||||||
| Disulfide bond | 541 ↔ 553 | By similarity | |||||||||
| Disulfide bond | 543 ↔ 560 | By similarity | |||||||||
| Disulfide bond | 562 ↔ 571 | By similarity | |||||||||
| Disulfide bond | 574 ↔ 584 | By similarity | |||||||||
| Disulfide bond | 587 ↔ 599 | By similarity | |||||||||
| Disulfide bond | 589 ↔ 605 | By similarity | |||||||||
| Disulfide bond | 607 ↔ 616 | By similarity | |||||||||
| Disulfide bond | 619 ↔ 629 | By similarity | |||||||||
| Disulfide bond | 632 ↔ 644 | By similarity | |||||||||
| Disulfide bond | 634 ↔ 650 | By similarity | |||||||||
| Disulfide bond | 652 ↔ 661 | By similarity | |||||||||
| Disulfide bond | 664 ↔ 674 | By similarity | |||||||||
| Disulfide bond | 677 ↔ 689 | By similarity | |||||||||
| Disulfide bond | 679 ↔ 696 | By similarity | |||||||||
| Disulfide bond | 698 ↔ 707 | By similarity | |||||||||
| Disulfide bond | 710 ↔ 725 | By similarity | |||||||||
| Disulfide bond | 746 ↔ 755 | By similarity | |||||||||
| Disulfide bond | 758 ↔ 773 | By similarity | |||||||||
| Disulfide bond | 776 ↔ 790 | By similarity | |||||||||
| Disulfide bond | 778 ↔ 797 | By similarity | |||||||||
| Disulfide bond | 799 ↔ 808 | By similarity | |||||||||
| Disulfide bond | 811 ↔ 826 | By similarity | |||||||||
| Disulfide bond | 829 ↔ 841 | By similarity | |||||||||
| Disulfide bond | 831 ↔ 848 | By similarity | |||||||||
| Disulfide bond | 850 ↔ 859 | By similarity | |||||||||
| Disulfide bond | 1438 ↔ 1450 | By similarity | |||||||||
| Disulfide bond | 1440 ↔ 1457 | By similarity | |||||||||
| Disulfide bond | 1459 ↔ 1468 | By similarity | |||||||||
| Disulfide bond | 1471 ↔ 1481 | By similarity | |||||||||
| Disulfide bond | 1484 ↔ 1491 | By similarity | |||||||||
| Disulfide bond | 1486 ↔ 1498 | By similarity | |||||||||
| Disulfide bond | 1500 ↔ 1509 | By similarity | |||||||||
| Disulfide bond | 1512 ↔ 1525 | By similarity | |||||||||
| Disulfide bond | 1528 ↔ 1543 | By similarity | |||||||||
| Disulfide bond | 1530 ↔ 1550 | By similarity | |||||||||
| Disulfide bond | 1552 ↔ 1561 | By similarity | |||||||||
| Disulfide bond | 1564 ↔ 1574 | By similarity | |||||||||
| Disulfide bond | 1577 ↔ 1589 | By similarity | |||||||||
| Disulfide bond | 1579 ↔ 1596 | By similarity | |||||||||
| Disulfide bond | 1598 ↔ 1607 | By similarity | |||||||||
| Disulfide bond | 1610 ↔ 1625 | By similarity | |||||||||
| Disulfide bond | 1864 ↔ 1873 | By similarity | |||||||||
| Disulfide bond | 1866 ↔ 1880 | By similarity | |||||||||
| Disulfide bond | 1883 ↔ 1892 | By similarity | |||||||||
| Disulfide bond | 1895 ↔ 1910 | By similarity | |||||||||
| Disulfide bond | 1913 ↔ 1928 | By similarity | |||||||||
| Disulfide bond | 1915 ↔ 1937 | By similarity | |||||||||
| Disulfide bond | 1939 ↔ 1948 | By similarity | |||||||||
| Disulfide bond | 1951 ↔ 1966 | By similarity | |||||||||
| Disulfide bond | 1969 ↔ 1984 | By similarity | |||||||||
| Disulfide bond | 1971 ↔ 1991 | By similarity | |||||||||
| Disulfide bond | 1994 ↔ 2003 | By similarity | |||||||||
| Disulfide bond | 2006 ↔ 2020 | By similarity | |||||||||
| Disulfide bond | 2023 ↔ 2033 | By similarity | |||||||||
| Disulfide bond | 2025 ↔ 2040 | By similarity | |||||||||
| Disulfide bond | 2042 ↔ 2051 | By similarity | |||||||||
| Disulfide bond | 2054 ↔ 2067 | By similarity | |||||||||
| Disulfide bond | 2070 ↔ 2081 | By similarity | |||||||||
| Disulfide bond | 2072 ↔ 2088 | By similarity | |||||||||
| Disulfide bond | 2090 ↔ 2099 | By similarity | |||||||||
| Disulfide bond | 2102 ↔ 2114 | By similarity | |||||||||
| Disulfide bond | 2117 ↔ 2124 | By similarity | |||||||||
| Disulfide bond | 2119 ↔ 2131 | By similarity | |||||||||
| Disulfide bond | 2133 ↔ 2142 | By similarity | |||||||||
| Disulfide bond | 2145 ↔ 2164 | By similarity | |||||||||
| Disulfide bond | 2167 | Interchain Probable | |||||||||
| Disulfide bond | 2170 | Interchain Probable | |||||||||
| Disulfide bond | 2899 ↔ 2929 | By similarity | |||||||||
| Disulfide bond | 3090 ↔ 3115 | By similarity | |||||||||
| Disulfide bond | 3261 ↔ 3292 | By similarity | |||||||||
| Disulfide bond | 3490 ↔ 3513 | By similarity | |||||||||
| Disulfide bond | 3664 ↔ 3692 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 401 | 1 | T → A. Ref.1 Corresponds to variant rs4925229 [ dbSNP | Ensembl ]. | VAR_047887 | |||||||
| Natural variant | 889 | 1 | V → M. Ref.3 Corresponds to variant rs6062223 [ dbSNP | Ensembl ]. | VAR_030847 | |||||||
| Natural variant | 1258 | 1 | M → T. Ref.1 Corresponds to variant rs3810548 [ dbSNP | Ensembl ]. | VAR_030848 | |||||||
| Natural variant | 1367 | 1 | K → E. Ref.1 Ref.3 Corresponds to variant rs2427286 [ dbSNP | Ensembl ]. | VAR_030849 | |||||||
| Natural variant | 1434 | 1 | G → A. Corresponds to variant rs17750870 [ dbSNP | Ensembl ]. | VAR_030850 | |||||||
| Natural variant | 1667 | 1 | R → W. Corresponds to variant rs13039398 [ dbSNP | Ensembl ]. | VAR_030851 | |||||||
| Natural variant | 1671 | 1 | T → M. Corresponds to variant rs944893 [ dbSNP | Ensembl ]. | VAR_047888 | |||||||
| Natural variant | 1717 | 1 | H → Y. Corresponds to variant rs875379 [ dbSNP | Ensembl ]. | VAR_030852 | |||||||
| Natural variant | 1807 | 1 | F → S. Ref.1 Ref.3 Corresponds to variant rs2427284 [ dbSNP | Ensembl ]. | VAR_030853 | |||||||
| Natural variant | 1900 | 1 | V → M. Ref.1 Corresponds to variant rs2427283 [ dbSNP | Ensembl ]. | VAR_030854 | |||||||
| Natural variant | 1908 | 1 | A → T. Corresponds to variant rs11698080 [ dbSNP | Ensembl ]. | VAR_030855 | |||||||
| Natural variant | 2036 | 1 | H → R. Corresponds to variant rs6143021 [ dbSNP | Ensembl ]. | VAR_030856 | |||||||
| Natural variant | 2053 | 1 | R → H. Corresponds to variant rs3737137 [ dbSNP | Ensembl ]. | VAR_030857 | |||||||
| Natural variant | 2062 | 1 | D → N. Ref.1 Ref.4 Corresponds to variant rs2274934 [ dbSNP | Ensembl ]. | VAR_030858 | |||||||
| Natural variant | 2226 | 1 | R → H. Corresponds to variant rs2297587 [ dbSNP | Ensembl ]. | VAR_030859 | |||||||
| Natural variant | 3079 | 1 | R → W. Ref.1 Ref.4 Ref.5 Corresponds to variant rs944895 [ dbSNP | Ensembl ]. | VAR_030860 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 956 | 1 | T → A in AAM12527. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cells." Doi M., Thyboll J., Kortesmaa J., Jansson K., Iivanainen A., Parvardeh M., Timpl R., Hedin U., Swedenborg J., Tryggvason K. J. Biol. Chem. 277:12741-12748(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ALA-401; THR-1258; GLU-1367; SER-1807; MET-1900; ASN-2062 AND TRP-3079. |
| [2] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins." Nagase T., Kikuno R., Ohara O. DNA Res. 8:179-187(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 197-1934, VARIANTS MET-889; GLU-1367 AND SER-1807. Tissue: Brain. |
| [4] | "Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro." Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 5:31-39(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2051-3695, VARIANTS ASN-2062 AND TRP-3079. Tissue: Brain. |
| [5] | "Tissue-specific expression of the human laminin alpha5-chain, and mapping of the gene to human chromosome 20q13.2-13.3 and to distal mouse chromosome 2 near the locus for the ragged (Ra) mutation." Durkin M.E., Loechel F., Mattei M.-G., Gilpin B.J., Albrechtsen R., Wewer U.M. FEBS Lett. 411:296-300(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2743-3695, VARIANT TRP-3079. Tissue: Placenta. |
| [6] | "Laminin expression in adult and developing retinae: evidence of two novel CNS laminins." Libby R.T., Champliaud M.-F., Claudepierre T., Xu Y., Gibbons E.P., Koch M., Burgeson R.E., Hunter D.D., Brunken W.J. J. Neurosci. 20:6517-6528(2000) [PubMed] [Europe PMC] [Abstract] Cited for: EXPRESSION IN RETINA. |
| [7] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2209; ASN-2303; ASN-2423; ASN-2501; ASN-2568; ASN-2707 AND ASN-3107, MASS SPECTROMETRY. Tissue: Liver. |
| [8] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [9] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF443072 mRNA. Translation: AAM12527.1. AL354836 Genomic DNA. Translation: CAC22310.1. Sequence problems. AB067494 mRNA. Translation: BAB67800.1. AB011105 mRNA. Translation: BAA25459.1. Z95636 mRNA. Translation: CAB09137.1. |
| IPI | IPI00783665. |
| RefSeq | NP_005551.3. NM_005560.3. |
| UniGene | Hs.473256. |
3D structure databases | |
| ProteinModelPortal | O15230. |
| SMR | O15230. Positions 42-427. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O15230. 7 interactions. |
| MINT | MINT-1183475. |
| STRING | 9606.ENSP00000252999. |
PTM databases | |
| PhosphoSite | O15230. |
Proteomic databases | |
| PaxDb | O15230. |
| PRIDE | O15230. |
Protocols and materials databases | |
| DNASU | 3911. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000252999; ENSP00000252999; ENSG00000130702. |
| GeneID | 3911. |
| KEGG | hsa:3911. |
| UCSC | uc002ycq.3. human. |
Organism-specific databases | |
| CTD | 3911. |
| GeneCards | GC20M060883. |
| H-InvDB | HIX0015978. |
| HGNC | HGNC:6485. LAMA5. |
| MIM | 601033. gene. |
| neXtProt | NX_O15230. |
| PharmGKB | PA30274. |
| HUGE | Search... Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG292643. |
| HOGENOM | HOG000231235. |
| HOVERGEN | HBG052300. |
| InParanoid | O15230. |
| KO | K06240. |
| OMA | LRHTTGP. |
| OrthoDB | EOG4VHK5G. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | a6b1_a6b4_integrin_pathway. a6b1 and a6b4 Integrin signaling. amb2_neutrophils_pathway. amb2 Integrin signaling. syndecan_1_pathway. Syndecan-1-mediated signaling events. |
Gene expression databases | |
| ArrayExpress | O15230. |
| Bgee | O15230. |
| CleanEx | HS_LAMA5. |
| Genevestigator | O15230. |
| GermOnline | ENSG00000130702. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.60.120.200. 5 hits. |
| InterPro | IPR008985. ConA-like_lec_gl_sf. IPR013320. ConA-like_subgrp. IPR013032. EGF-like_CS. IPR002049. EGF_laminin. IPR018031. Laminin_B_subgr. IPR000034. Laminin_B_type_IV. IPR001791. Laminin_G. IPR009254. Laminin_I. IPR010307. Laminin_II. IPR008211. Laminin_N. IPR001368. TNFR/NGFR_Cys_rich_reg. [Graphical view] |
| Pfam | PF00052. Laminin_B. 1 hit. PF00053. Laminin_EGF. 19 hits. PF02210. Laminin_G_2. 5 hits. PF06008. Laminin_I. 1 hit. PF06009. Laminin_II. 1 hit. PF00055. Laminin_N. 1 hit. [Graphical view] |
| SMART | SM00180. EGF_Lam. 20 hits. SM00281. LamB. 1 hit. SM00282. LamG. 5 hits. SM00136. LamNT. 1 hit. [Graphical view] |
| SUPFAM | SSF49899. ConA_like_lec_gl. 5 hits. |
| PROSITE | PS00022. EGF_1. 19 hits. PS01186. EGF_2. 3 hits. PS01248. EGF_LAM_1. 19 hits. PS50027. EGF_LAM_2. 21 hits. PS50025. LAM_G_DOMAIN. 5 hits. PS51115. LAMININ_IVA. 1 hit. PS51117. LAMININ_NTER. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | LAMA5. human. |
| DrugBank | DB00009. Alteplase. DB00029. Anistreplase. DB00015. Reteplase. DB00031. Tenecteplase. |
| GenomeRNAi | 3911. |
| NextBio | 15363. |
| SOURCE | Search... |
Entry information
| Entry name | LAMA5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O15230 Secondary accession number(s): Q8TDF8, Q8WZA7, Q9H1P1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
